EANS-News: Intercell AG /Intercell announces positive results from two clinical Phase III studies supporting pediatric label extension of JE vaccine for children traveling to endemic areas
Research & Development Wien (euro adhoc) - - » Japanese Encephalitis (JE) vaccine showed to be highly immunogenic in children aged 2 months to ...